ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Small Cell Lung Carcinoma
Colorectal Cancer
Squamous Cell Carcinoma of Head and Neck
Breast Cancer
Carcinoma

Lung Cancer trials near Indianapolis, IN, USA:

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Enrolling
Limited Stage Small Cell Lung Cancer
Drug: Durvalumab
Drug: BMS-986489

Phase 2

SCRI Development Innovations

Indianapolis, Indiana, United States and 26 other locations

combination, lurbinectedin with osimertinib, against a rare type of cancer known as transformed small cell lung cancer (SC...

Begins enrollment in 2 months
Small Cell Lung Cancer ( SCLC )
Transformed Small Cell Lung Cancer
Drug: Osimertinib
Drug: Lurbinectedin

Phase 1, Phase 2

Misty Shields

Indianapolis, Indiana, United States

This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung ...

Enrolling
Stage IVA Lung Cancer AJCC v8
Recurrent Lung Small Cell Carcinoma
Drug: Temozolomide
Biological: Atezolizumab

Phase 2

Dwight Owen

Indianapolis, Indiana, United States and 4 other locations

PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer ...

Enrolling
Small Cell Lung Cancer
Drug: Alisertib

Phase 2

Puma Biotechnology
Puma Biotechnology

Indianapolis, Indiana, United States and 29 other locations

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...

Active, not recruiting
Small Cell Lung Cancer
Drug: Durvalumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Muncie, Indiana, United States and 182 other locations

of previously-untreated patients with extensive stage small cell lung cancer. Patients will receive initial chemo-immunotherapy fol...

Enrolling
Extensive Stage Small Cell Lung Cancer
Drug: Cisplatin
Drug: Ceralasertib

Phase 2

Muhammad Furqan

Indianapolis, Indiana, United States and 4 other locations

The main objective is to compare the efficacy of tarlatamab with standard of care (SOC) on prolonging overall survival (OS).

Active, not recruiting
Small Cell Lung Cancer (SCLC)
Drug: Topotecan
Drug: Amrubicin

Phase 3

Amgen
Amgen

Indianapolis, Indiana, United States and 224 other locations

following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 c...

Enrolling
NSCLC, Stage I
Drug: Pembrolizumab

Phase 2

Greg Durm, MD

Indianapolis, Indiana, United States and 12 other locations

antibody in participants with advanced or metastatic non-small cell lung cancer (NSCLC). Cohort A will enroll participants who have...

Enrolling
Non Small Cell Lung Cancer
Drug: tolododekin alfa
Drug: Cetrelimab

Phase 1

Ankyra Therapeutics

Indianapolis, Indiana, United States and 4 other locations

The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment....

Enrolling
Immunotherapy
Stage IV NSCLC
Dietary Supplement: FMD
Combination Product: Regular Diet Plus FMD
VA Office of Research and Development
VA Office of Research and Development

Indianapolis, Indiana, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems